Phosphorus Acid Patents (Class 424/605)
-
Patent number: 6541421Abstract: This invention relates to a buffered phosphorus containing solution comprising at least one phosphorus compound selected from the group consisting of phosphorous acid, hypophosphorous acid, polyphosphorous acid polyhypophosphorous acid, and salts thereof. The solution also contains a buffer including an organic base in the form of a nitrogen containing compound and its conjugate acid. The solution may be used as a fertilizer or as a fungicide. The invention also relates to a method of preparing such a solution.Type: GrantFiled: October 4, 2000Date of Patent: April 1, 2003Inventors: Alastair James Forsyth, Tomasz Antoni Modro
-
Patent number: 6538038Abstract: Treatment of warm-blooded animals having a tumor or non-malignant hypervascularation, by administering a sufficient amount of a cytotoxic agent formulated into a phosphate prodrug form having substrate specificity for microvessel phosphatases, so that microvessels are destroyed preferentially over other normal tissues, because the less cytotoxic prodrug form is converted to the highly cytotoxic dephosphorylated form.Type: GrantFiled: February 16, 2000Date of Patent: March 25, 2003Assignee: OXiGENE, Inc.Inventors: Ronald W. Pero, David Sherris
-
Patent number: 6524624Abstract: A two-part disinfecting systems, as well as disinfecting compositions and methods for making and using the same. The two-part disinfecting system contains a first part and a second part adapted to be mixed to yield an aqueous disinfecting composition, wherein the first part comprises a chlorite and the second part comprises an acid and an optional oxidizable colorant, and wherein the first part, the second part, or both the first and second parts comprise an alpha olefin sulfonate.Type: GrantFiled: May 16, 2001Date of Patent: February 25, 2003Assignee: Alcide CorporationInventors: Joseph Morelli, C. Cayce Warf, Jr., Maura Aldrich, Cecilia Moser Morse, Jean Wiley
-
Publication number: 20030035847Abstract: A composition and therapeutic methods therefore for pharmacologically strong acid solutions comprising a mixture of strong and weak acids.Type: ApplicationFiled: April 2, 2002Publication date: February 20, 2003Inventor: David Martucci
-
Patent number: 6521264Abstract: A solid powder product with a Ca/P ratio of between 1.40 and 1.90 is prepared from tricalcium phosphate and tetracalcium phosphate. An aqueous solution containing calcium ions and phosphate ions with a Ca/P ratio higher than 0.20 and lower than 0.50 is prepared. The aqueous solution and the solid powder product and optionally water are mixed to obtain a mixture with a liquid/solid weight ratio of between 0.30 and 0.65 and a resulting paste with a Ca/P ratio of between 1.50 and 1.67.Type: GrantFiled: January 11, 2000Date of Patent: February 18, 2003Assignee: TeknimedInventors: Jean-Louis Lacout, Zinèb Hatim, Michele Frache-Botton
-
Patent number: 6509041Abstract: A fungicidal composition for plants containing phosphonate (PO3) and phosphate (PO4) salts, and derivatives thereof is disclosed. The composition provides a single product which may be employed to control a Phytophthora infestans infection in plants.Type: GrantFiled: September 18, 2001Date of Patent: January 21, 2003Assignee: Foliar Nutrients, Inc.Inventor: John B. Taylor
-
Publication number: 20020192297Abstract: An acidic aqueous hydrogen peroxide solution is provided with improved disinfectant activity. Concentrated solutions preferably contain up to about 8 wt./wt. % H202 and as-used concentrations contain about 0.5 % wt./wt. % H202. The solution also contains from 0.05 to 8.0 wt./wt. % of at least one phosphorous-based acid, e.g. phosphoric acid and/or a phosphonic acid with from 1 to 5 phosphonic acid groups, and from 0.02 to 5 wt./wt. % of at least one anionic surfactant. The surfactant is selected from C8 to C16 alkyl aryl sulfonic acids, sulfonated C12 to C22 carboxylic acids, C8 to C22 alkyl diphenyl oxide sulfonic acids, naphthalene sulfonic acids, C8 to C22 alkyl sulfonic acids, and alkali metal and ammonium salts thereof, and alkali metal C8 to C18 alkyl sulfates, and mixtures thereof. Most preferably the solution has an emulsifier and/or hydrotrope, e.g. an alkylated sulfonated diphenyl oxide salt, an alkyl aryl polyoxyethylene surfactant, and/or a polyoxyethylene surfactant.Type: ApplicationFiled: December 28, 2001Publication date: December 19, 2002Inventors: Jose A. Ramirez, Michael J. Rochon
-
Publication number: 20020182264Abstract: The invention relates to solutions containing acidic compositions that have a pH of less than 1, are non-caustic to human tissue and are safe for human ingestion. These compositions may be used as the sole or major component of solutions such as cleansers, pharmaceuticals, food preservatives and disinfectants. The acidic compositions may be used in medical, industrial, military and household applications. The invention also relates methods of administering and using the acidic compositions of the invention.Type: ApplicationFiled: April 9, 2002Publication date: December 5, 2002Inventors: Ernest G. Roden, John R. Dankert
-
Acetate-lactate buffering vaginal gel and for method of making same and treating bacterial vaginosis
Publication number: 20020177624Abstract: A composition of matter comprising a pH buffering system comprising a combination of lactic acid and related base salt that occur naturally in the human female body that, when applied to the surface of the vagina, maintains the pH level thereon at approximately the pH level of a healthy vagina. The composition my include a gel form, and also contain acetic acid as well as polyethylene glycol, glycerol and oxyquinoline.Type: ApplicationFiled: March 16, 2001Publication date: November 28, 2002Inventors: Calvin Hanna, Lindley A Cates -
Patent number: 6476069Abstract: A composition useful as an embolic agent that selectively creates an embolic blockage in the lumen of a blood vessel, duct, fistula or other like body passageways by combining a monomer component and a second component wherein, said monomer component comprises of a alkyl cyanoacrylate monomer and at least one inhibitor agent; and said second component that functions as an opacificant agent and a polymerization retardant.Type: GrantFiled: January 29, 1999Date of Patent: November 5, 2002Assignee: Provasis Therapeutics Inc.Inventors: Robert E. Krall, Charles W. Kerber, Kimberly Knox
-
Patent number: 6476070Abstract: A composition comprising of a monomer component comprised of at least one alkyl cyanoacrylate and at least one inhibitor, and a second component comprised of a resultant aggregate structure formed from an alkyl cyanoacrylate monomer, an alkyl esterified fatty acid and an opacificant agent where said composition forms a resultant aggregate structure when said composition contacts an anionic environment. The compositions are useful for filling, occluding, partially filling or partially occluding an unfilled volume or space in a mass in an anionic environment. The composition are also useful for ablating diseased or undesired tissue by cutting off the blood supply to the tissue.Type: GrantFiled: February 2, 2000Date of Patent: November 5, 2002Assignee: Provasis Therapeutics Inc.Inventors: Robert E. Krall, Charles W. Kerber, Kimberly Knox
-
Patent number: 6455075Abstract: A method for control of insects on plant tissue which includes applying a solution tht includes hydrogen peroxide to the plant tissue. The hydrogen peroxide solution has a concentration of between 0.05 to 3.00%. In some cases the hydrogen peroxide solution has a concentration of between 0.05 and 1.5%. Some forms of the invention may utilize a hydrogen peroxide solution that further includes an acid selected from the group consisting of acetic acid and phosphoric acid. Various structures are used for applying the hydrogen peroxide solution such as hydraulic spraying, misting, fogging, or injecting the hydrogen peroxide into a commercial cooling system. In some cases the hydrogen peroxide solution is applied to the plant tissue at a variety of stages in the plant production cycle. Other application of the invention include applying misting the hydrogen peroxide solution over terminal stem cuttings until they reach root sufficiency.Type: GrantFiled: January 12, 1998Date of Patent: September 24, 2002Inventor: Rene N. Larose
-
Patent number: 6448240Abstract: The invention concerns a synergetic fungicide and/or bactericide composition comprising famoxadone and a phosphorous acid derivative; and a method for fighting, for cure or prevention, against phytopathogenic fungi and/or bacteria using such a composition.Type: GrantFiled: August 10, 2000Date of Patent: September 10, 2002Assignee: Aventis CropScience, S.A.Inventors: Bernadette Givois, Marie-Pascale Latorse
-
Patent number: 6436444Abstract: The mastitis control teat dip composition of the invention provides rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition that is stable over an extended period of time, and unexpected long term microbial control when compared to the prior art materials disclosed in patents and used in the marketplace. The compositions of the invention are made by combining an aqueous thickened liquid composition containing the organic components which can be combined with a simple aqueous solution of a salt of chlorous acid, preferably an alkali metal chlorite. The materials can be combined, blended into a smooth viscous material and can be immediately contacted with the target animals. The .compositions of the invention provide rapid initial kill, consistent long term kill and chemical and rheological stability.Type: GrantFiled: September 26, 1997Date of Patent: August 20, 2002Assignee: Ecolab Inc.Inventors: Francis L. Richter, Cathy M. Paquette, Richard K. Staub
-
Patent number: 6423348Abstract: What is shown is an animal blood anticoagulant compound useful in the meat packing industry generally, and in slaughterhouse operations, particularly. The anticoagulant is effective when diluted with water at higher dilution ratios than earlier anticoagulants. In some field trials, this anticoagulant was at least as effective as previously known commercial anticoagulants when diluted by an additional 30%. The present anticoagulant preparation concentrate is an aqueous mixture of soft water (55.0%-65.0/%, w/w); tetrasodium ethylene diamine tetraacetate (Na4EDTA) (0.5%-3.0%, w/w); sodium hexametaphosphate (17.0%-24.0%, w/w); citric acid (5.0%-9.0%, w/w); and sodium hydroxide (4.0%-7.0%, w/w) to obtain a balanced pH that provides optimal chelating and anticoagulant activity. Optimal anticoagulant performance has been found to occur in the range of between pH 6.6 and pH 7.2.Type: GrantFiled: December 15, 1998Date of Patent: July 23, 2002Inventor: James C. Mickus
-
Publication number: 20020058072Abstract: A method of increasing vaginal lubrication in an adult human female by orally administering to the female an effective amount of an acidic solution having a pharmaceutically acceptable water-soluble iodide salt, wherein hydriodic acid is generated in situ.Type: ApplicationFiled: October 26, 2001Publication date: May 16, 2002Inventor: Susann Reilly
-
Publication number: 20020048609Abstract: A fungicidal composition for plants containing phosphonate (PO3) and phosphate (PO4) salts, and derivatives thereof is disclosed. The composition provides a single product which may be employed to control a Phytophthora infestans infection in plants.Type: ApplicationFiled: September 18, 2001Publication date: April 25, 2002Inventor: John B. Taylor
-
Patent number: 6368610Abstract: A disinfecting composition which is bactericidal and effective to kill yeast includes (a) at least one a monocarboxylic acid of formula R—COOH, in which R a saturated or unsaturated, straight- or branched-chain alkyl radical comprising from 6 to 12 carbon atoms; (b) a strong inorganic acid; (c) at least one organic acid of formula R′CH2—CO2H, in which R′ is H or OH; (d) at least one anionic surfactant; (e) at least one solubilizing agent consisting of a compound of formula R″O(CH2CH2O)x—H, in which R″ represents a C2 to C6 alkyl radical, x represents an integer from 1 to 3; and (f) water.Type: GrantFiled: February 7, 2000Date of Patent: April 9, 2002Assignee: SOPURA S.A.Inventors: Nicolas Velings, Ferdinand Herman, Paul-Eric Loncin
-
Patent number: 6358938Abstract: Synergistic fungicidal composition comprising propamocarb and a derivative of phosphorous acid; and process for the curative or preventative control of phytopathogenic fungi by use of such a composition.Type: GrantFiled: February 15, 2000Date of Patent: March 19, 2002Assignee: Rhone-Poulenc AgroInventors: Joëlle Donnadieu, Patrice Duvert, Richard Mercer
-
Patent number: 6350474Abstract: The invention deals with phosphate water solution with cold solidification capacity. Phosphate composition containing iron oxide solution in acid, water, advantages from the following properties; it contains orthophosphorus acid and in addition metal powder. Phosphate composition is ecologically pure product, non toxic, non cancerogenic, non-allergic. It has antimicrobial, antivirus and fungicidal properties. Phosphate composition can be applied within medicine: surgery, dermatology, dentistry, oncology, pharmacology and other branches. In agriculture use: as a means of curing plant diseases, within veterinary—as a means for preventive maintenance and curing of animal diseases, within construction—as an anticorrosive, fire-resistant, hydro-electric isolating covers, ceramic tiles, concretes, which protect against radiation, as well as for producing other composite materials.Type: GrantFiled: June 7, 1999Date of Patent: February 26, 2002Inventors: David Dzneladze, Andro Dzneladze, Nargisa Jabishvili
-
Patent number: 6346279Abstract: An acidic aqueous hydrogen peroxid solution is provided, with improved disinfectant activity. Concentrated solutions preferably contain up to about 8% and as-used concentrations contain about 0.5% peroxide. The solution also contains from 0.1 to 5.0% of at least one acid compound, e.g. phosphoric and/or a phosphonate with from 1 to 5 phosphonic acid groups, and from 0.02 to 5% of at least one anionic surfactant. The surfactant is selected from C8 to C16-alkyl aryl sulphonic acids, sulphonated C12 to C22 carboxylic acids, C8 to C22-alkyl diphenyl oxide sulphonic acids, naphthalene sulphonic acids, C8 to C22 alkyl sulphonic acids, and alkali metal and ammonium salts thereof, and alkali metal C8 to C18 alkyl sulphates, and mixtures thereof. Most preferably the solution has an emulsifier, e.g. a salt of an alkylated diphenyl oxide. The solution may also contain corrosion inhibitors and/or lower alcohols.Type: GrantFiled: July 19, 1999Date of Patent: February 12, 2002Assignee: Virox Technologies, Inc.Inventor: Michael J. Rochon
-
Patent number: 6344218Abstract: The present invention relates to aqueous compositions comprising an odor controlling agent and select sanitizing agents for deodorizing and sanitizing skin surfaces. Articles of manufacture and methods of deodorizing and sanitizing the skin using disclosed compositions are also disclosed.Type: GrantFiled: May 27, 1999Date of Patent: February 5, 2002Assignee: The Procter & Gamble CompanyInventors: Michael Thomas Dodd, Karl Shiqing Wei, Toan Trinh, Mark Richard Sine, Robert Gregory Bartolo, David Andrew Jakubovic
-
Patent number: 6338860Abstract: A fungicidal composition for plants containing phosphonate (PO3) and phosphate (PO4) salts, and derivatives thereof is disclosed. The composition provides a single product which may be employed to control a Phytophthora infestans infection in plants.Type: GrantFiled: October 15, 1999Date of Patent: January 15, 2002Assignee: Foliar Nutrients, Inc.Inventor: John B. Taylor
-
Patent number: 6303155Abstract: A method for restoration of the circadian rhythm of parathyroid hormone (PTH) serum levels in a subject having osteoporosis, so as to restore a circadian rhythm of PTH levels which is similar to that existing in normal subjects is disclosed by administering a single daily dose of a composition consisting essentially of an effective amount of phosphate in the evening or at night, whereby the composition causes a circadian rhythm of PTH levels which peaks during the night, whereby the circadian rhythm of PTH levels is restored to that which is similar to that existing in normal subjects, thereby treating osteoporosis.Type: GrantFiled: March 1, 1999Date of Patent: October 16, 2001Assignee: Hadasit Medical Research Services and Development Company, Ltd.Inventor: Justin Silver
-
Patent number: 6264993Abstract: The present invention relates to fungicidal compositions and their use as a method for controlling phytopathogenic fungi comprising the application of a selected fungicidally active N-acetonylbenzamide compound and a second fungicidally active compound selected from the group consisting of an inhibitor of respiration at cytochrome complex III, ziram, fluazinam, zarilamide, chlorothalonil, propamocarb, folpet, fosetyl-aluminum or a fungitoxic metabolite thereof, phosphorous acid or a salt thereof, a triphenyltin type fungicide and a copper containing fungicide to plant seed, to plant foliage or to a plant growth medium. The compositions and method of use provide higher fungicidal activity than separate use of the same compounds.Type: GrantFiled: April 28, 2000Date of Patent: July 24, 2001Assignee: Rohm and Haas CompanyInventors: David Hamilton Young, Willie Joe Wilson, Anne Ritchie Egan, Enrique Luis Michelott
-
Publication number: 20010007864Abstract: Method for improving the fruit yields from banana plants, characterized in that an effective and non-phytotoxic dose of a compound A, chosen from:Type: ApplicationFiled: December 13, 1996Publication date: July 12, 2001Inventors: JORGE GONZALES, JORGE CEPEDA, JUAN BOCANEGRA
-
Patent number: 6197815Abstract: Metal amino acid chelates for animals are beneficial for facilitating and promoting growth by increasing desired metallic ion uptake. The present invention is directed to a process for providing an animal fed additive by preparing metal amino acid chelates, and the metal amino acid chelate growth facilitator, promoter and enhancer prepared by the process.Type: GrantFiled: March 18, 1998Date of Patent: March 6, 2001Assignee: J.H. Biotech, Inc.Inventor: Hsinhung John Hsu
-
Patent number: 6156740Abstract: Synergistic fungicidal composition comprising a compound analogous to strobilurin of formula (I): ##STR1## in which: A is the nitrogen atom or the --CH group,B is the --OCH.sub.2 -- or --CH.sub.2 O-- or CH(CH.sub.3)--O--N.dbd.CH-- or --CH.dbd.N--O--CH(CH.sub.3)-- group or the group ##STR2## R.sub.1 is an alkyl group containing 1 to 4 carbon atoms, R.sub.2 is --OCH.sub.3 or --NHCH.sub.3,X is a halogen atom, the cyano group or an alkyl or haloalkyl group containing 1 to 4 carbon atoms,n is equal to 1 or 2, with, when n is equal to 2, the possibility of having different X groups,and at least one fungicidal compound B, anda process for the curative or preventive control of phytopathogenic fungi using the composition.Type: GrantFiled: December 1, 1999Date of Patent: December 5, 2000Assignee: Rhone-Poulenc AgrochimieInventor: Patrice Duvert
-
Patent number: 6123966Abstract: A stabilized two-part disinfecting system comprising a first part and a second part adapted to be mixed to yield an aqueous disinfecting composition. The first part contains a non-esterifying acid and an alcohol-containing humectant or antifreeze, while the second part contains a salt of an organic acid and an optional metal chlorite. Methods for making a disinfecting composition by mixing the two-part disinfecting system, as well as for disinfecting substrates by contact therewith, are also disclosed.Type: GrantFiled: September 3, 1998Date of Patent: September 26, 2000Assignee: Alcide CorporationInventor: Robert D. Kross
-
Patent number: 6113949Abstract: This invention relates to a weight control composition, preferably in the form of a capsule or tablet, comprising a mixture of guggul extract and at least one phosphate salt selected from calcium phosphate, potassium phosphate and sodium phosphate. The composition evidences synergistic activity in reducing body weight and percent body fat in mammals. The guggul extract/phosphate salt product also reduces plasma lipid levels and cholesterol in overweight hyperlipidaemic humans. The inventive composition may also contain at least one additional component selected from phosphatidylcholine, hydroxycitric acid and L-tyrosine.Type: GrantFiled: October 27, 1998Date of Patent: September 5, 2000Assignee: Prolab Nutrition, Inc.Inventor: William DesIsles Brink
-
Patent number: 6037366Abstract: A composition including 2-hexyl cyanoacrylate and gold is useful in treating arteriovenous malformations (AVMs) and other body lumens to be blocked.Type: GrantFiled: September 11, 1998Date of Patent: March 14, 2000Assignee: Prohold Medical Technologies, Inc.Inventors: Robert E. Krall, Charles W. Kerber, Kimberly Knox
-
Patent number: 6024985Abstract: The invention provides a synthetic bone precursor material comprising amorphous calcium phosphate and a constituent that inhibits the crystallisation of calcium hydroxyapatite to amorphous calcium phosphate. The synthetic bone precursor may comprise a material of formula CaxMgyPO4 wherein Mg acts as an inhibitor for crystallisation. Other crystallisation inhibitors such as pyrophosphate may be present. The inhibitor is capable of dissolving in physiological saline. Loss of inhibitor from the precursor allows crystallisation of hydroxyapatite. The invention relates to use of a synthetic bone precursor to form bone in vivo, by a transformation of the amorphous precursor material to crystalline hydroxyapatite bone material by the leaching action on inhibitory ions body fluids. it is envisaged that the material will be useful in facilitating bone repair, inducing bone formation or assisting in the attachment of prostheses.Type: GrantFiled: April 5, 1995Date of Patent: February 15, 2000Assignee: University of ReadingInventors: Kenneth Simkiss, Marina Gloria Taylor
-
Patent number: 6015802Abstract: Synergistic fungicidal composition comprising a compound analogous to strobilurin of formula (I): ##STR1## in which: A is the nitrogen atom or the --CH group,B is the --OCH.sub.2 -- or --CH.sub.2 O-- or CH(CH.sub.3)--O--N.dbd.CH-- or --CH.dbd.N--O--CH(CH.sub.3)-- group or the group ##STR2## R.sub.1 is an alkyl group containing 1 to 4 carbon atoms, R.sub.2 is --OCH.sub.3 or --NHCH.sub.3,X is a halogen atom, the cyano group or an alkyl or haloalkyl group containing 1 to 4 carbon atoms,n is equal to 1 or 2, with, when n is equal to 2, the possibility of having different X groups,and at least one fungicidal compound B, anda process for the curative or preventive control of phytopathogenic fungi using the composition.Type: GrantFiled: May 13, 1998Date of Patent: January 18, 2000Assignee: Rhone-Poulenc AgrochimieInventor: Patrice Duvert
-
Patent number: 5997910Abstract: A fertilizer composition for plants containing phosphonate and phosphate slats, and derivatives thereof is disclosed. The composition provides a single product which may be employed to stimulate the growth response in plants.Type: GrantFiled: July 2, 1998Date of Patent: December 7, 1999Inventor: John B. Taylor
-
Patent number: 5952010Abstract: Carbonated hydroxyapatite compositions and their preparation are described. The compositions are biologically resorbable and are prepared as flowable masses which can be administered by syringe to set in situ to serve as a support structure, filler, prosthesis or the like.Type: GrantFiled: December 9, 1997Date of Patent: September 14, 1999Assignee: Norian CorporationInventor: Brent R. Constantz
-
Patent number: 5925383Abstract: A fungicidal composition for plants containing phosphonate and phosphate salts, and derivatives thereof is disclosed. The composition provides a single product which may be employed to control a parasitic fungi in plants through mitigation of pathological acerbation of certain fungi.Type: GrantFiled: October 2, 1997Date of Patent: July 20, 1999Inventor: John B. Taylor
-
Patent number: 5915969Abstract: A tooth having a tooth surface with a plurality of tubules and microchannels defined therein is treated with a polymeric hydrogel formed by a polyphosphazene substance and a metal salt. The polyphosphazene substance is first applied to the tooth surface and then the metal salt is applied thereto. The polyphosphazene substance is reacted with the metal salt to form a polymeric hydrogel inside the tubules.Type: GrantFiled: October 20, 1998Date of Patent: June 29, 1999Inventor: Lars .ANG.ke Linden
-
Patent number: 5906986Abstract: A fungicidal composition comprising a compound A having the formula: ##STR1## wherein M is an oxygen or sulphur atom, n is 0 or 1, and Y is a fluorine or chlorine atom or a methyl radical; and at least one fungicidal compound B. A method for preventing or controlling phytopathogenic fungi on crops by applying an effective and non-plant-poisonous amount of said compound on the exposed parts of the plants is also disclosed.Type: GrantFiled: May 6, 1997Date of Patent: May 25, 1999Assignee: Rhone Poulenc AgrochimieInventor: Marie-Pascale Latorse
-
Patent number: 5900254Abstract: Carbonated hydroxyapatite compositions and their preparation are described. The compositions are biologically resorbable and are prepared as flowable masses which can be administered by syringe to set in situ to serve as a support structure, filler, prosthesis or the like. Optionally the compositions may include proteins or serve as a depot for compositions of phrarmacological interest.Type: GrantFiled: June 27, 1996Date of Patent: May 4, 1999Assignee: Norian CorporationInventor: Brent R. Constantz
-
Patent number: 5863563Abstract: Methods and compositions for the treatment of the symptoms of a patient who has a pulmonary condition associated with an inhibition of surfactant secretion by type II alveolar cells are described. The method of treatment involves causing a patient to inhale an amount of a pH-raising buffer effective to raise the pH of the aqueous fluid in the microenvironment of the type II alveolar cell lumenal surface, thereby inducing an increase in the rate of surfactant secretion by type II alveolar cells.Type: GrantFiled: October 20, 1994Date of Patent: January 26, 1999Assignee: AlphaGene Inc.Inventor: George Scheele
-
Patent number: 5800837Abstract: A fertilizer composition for plants containing phosphonate and phosphate slats, and derivatives thereof is disclosed. The composition provides a single product which may be employed to stimulate the growth response in plants.Type: GrantFiled: March 6, 1997Date of Patent: September 1, 1998Assignee: Foliar Nutrients, Inc.Inventor: John B. Taylor
-
Patent number: 5801034Abstract: This invention provides a method for killing cells in fermentation mixtures in order to prepare the fermentation mixture for processing to recover or extract a desired product from the fermentation mixture. A preferred method of this invention comprises in either order, adjusting the pH of the fermentation mixture to a value equal to or less than about two pH units below the pK.sub.a of the compatible organic acid using a mineral acid, and adding a sufficient amount of a compatible organic acid and/or organic acid salt to the mixture to effect a substantially complete cell kill. The method of this invention is useful for killing microorganisms such as yeast, bacteria or fungi in any culture or fermentation mixture and is particularly useful in systems where it is desired to kill the cells without lysing them.Type: GrantFiled: December 14, 1994Date of Patent: September 1, 1998Assignee: Genencor InternationalInventors: Virgil B. Lawlis, Jr., Henry G. Heinsohn, Enrique F. Baliu
-
Patent number: 5736164Abstract: A fungicidal composition for plants containing phosphonate and phosphate salts, and derivatives thereof is disclosed. The composition provides a single product which may be employed to control parasitic fungi in plants through mitigation of pathological acerbation of certain fungi.Type: GrantFiled: August 30, 1996Date of Patent: April 7, 1998Inventor: John B. Taylor
-
Patent number: 5723406Abstract: A method for control of horticulture diseases and decontamination of plant tissue which includes applying a solution of hydrogen peroxide to plant tissue, said hydrogen peroxide being a solution having a concentration of between 0.05 to 3.00%. In some cases the hydrogen peroxide solution has a concentration of between 0.05 and 1.5%. Some forms of the invention may utilize a hydrogen peroxide solution that further includes an acid selected from the group consisting of acetic acid and phosphoric acid. Various structures are used for applying the hydrogen peroxide solution such as hydraulic spraying, misting, fogging, or injecting the hydrogen peroxide into a commercial cooling system. In other cases the hydrogen peroxide solution is injected into a recirculating subirrigation nutrient system solution to control microbial growth in the irrigation water. In some cases the hydrogen peroxide solution is applied to the plant tissue at a variety of stages in the plant production cycle.Type: GrantFiled: January 2, 1996Date of Patent: March 3, 1998Inventors: Rene N. Larose, Michael N. Abbot
-
Patent number: 5707611Abstract: A tooth surface treating agent is provided which comprises a polymerization catalyst and an acidic compound, both water-soluble, the treating agent being capable of enhancing tooth adhesion. The tooth surface treating agent imparts strong adhesion to the enamel and dentin of teeth through simultaneous treatment thereof. The invention is mainly intended for use in the field of dentistry, but is also applicable as a treating agent for vital hard tissues in such fields as surgery, and orthopaedic or plastic surgery.Type: GrantFiled: December 7, 1995Date of Patent: January 13, 1998Assignee: Kabushiki Kaisha ShofuInventors: Kunio Ikemura, Yoshiaki Kouro, Hisaaki Tachidokoro, Katsuya Kimoto
-
Patent number: 5698229Abstract: An antimicrobial composition, characterized by containing an inorganic compound on which silver ion is supported and a compound represented by the following formula ?2!: ##STR1## wherein R.sup.1 is hydrogen or a lower alkyl group and R.sup.2 is hydrogen or an alkali metal.Type: GrantFiled: June 25, 1993Date of Patent: December 16, 1997Assignee: Toagosei Co., Ltd.Inventors: Shuichi Ohsumi, Hideki Kato
-
Patent number: 5656652Abstract: Compositions for oral administration for the treatment of gastric disorders comprising histamine H.sub.2 -receptor antagonist, and antacid, optimally buffered to promote local absorption of the H.sub.2 -receptor antagonist, wherein the quantity of H.sub.2 -receptor antagonist per unit dosage form is less than 25 mg.Type: GrantFiled: June 15, 1994Date of Patent: August 12, 1997Assignee: SmithKline Beecham plcInventor: Adrian Francis Davis
-
Patent number: 5653973Abstract: Baits useful for controlling lepidoptera populations is made with (a) a diet component for lepidoptera; (b) a toxicant; (c) a chemiluminescent, visual attractant and (d) an encapsulating agent that will allow moisture to permeate and form an external condensate of said diet and said toxicant. The diet, toxicant, and chemiluminescent visual attractant can be used in the same bait particle in a homogeneous or layered structure. Alternatively, the diet/toxicant may be used with a first encapsulating agent in a first bait particle with the chemiluminescent, visual attractant encapsulated in a second bait particle and distributed among the diet/toxicant bait particles.Type: GrantFiled: August 16, 1996Date of Patent: August 5, 1997Assignee: Micro Flo CompanyInventors: Chel W. Lew, Keith Branly, Jesse Gaytan, Osborn Jones Turner
-
Patent number: 5629026Abstract: Compositions for oral administration for the treatment of gastric disorders comprising histamine H.sub.2 -receptor antagonist and antacid, optionally buffered to promote local absorption of the H.sub.2 -receptor antagonist, wherein the quantity of H.sub.2 -receptor antagonist per unit dosage form is less than 25 mg.Type: GrantFiled: May 17, 1995Date of Patent: May 13, 1997Assignee: SmithKline Beecham plcInventor: Adrian F. Davis
-
Patent number: 5626883Abstract: A vitamin C supplement comprising ascorbic acid, ascorbyl palmitate, niacinamide ascorbate, calcium ascorbate, magnesium ascorbate, potassium ascorbate, and sodium ascorbate which together can be administered to a human to avoid the transitory initial suppression of human NK cell activity which is present when ascorbic acid alone is administered. Also included is xylitol, lysine acetate, tetrasodium pyrophosphate, ribose, cysteine, and hesperidin which further prolongs the biological activity of ascorbic acid and promotes the uptake of ascorbic acid by human tissue.Type: GrantFiled: April 15, 1994Date of Patent: May 6, 1997Assignee: Metagenics, Inc.Inventor: Stephen M. Paul